1 month
+3.9%
price return
Year to date
-5.9%
price return
Recent earnings
3/4
quarters beat
Big funds
8
hold this stock
News tone
Bullish
50 articles, 7 days
Analysts
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsWhat it reported, what was expected, and what comes next.
Reported Jul 30, 2026
Earnings per share
$3.46 expected
Next report
EPS expected
$3.44 to $3.80
Revenue expected
25 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
From the release
The three statements, quarter by quarter.
Sep 2025 to Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| RevenueTotal revenue | $6.06B | $7.17B | $6.02B | $6.59B |
| Cost of what it soldCost of revenue | $2.21B | $2.49B | $2.21B | $2.09B |
| Gross profit | $3.85B | $4.68B | $3.81B | $4.50B |
| What it spent | ||||
| Research and development | $410.0M | $401.0M | $413.0M | $434.0M |
| Sales and adminSelling, general and administrative | $2.04B | $2.13B | $2.28B | $2.23B |
| Other operating costsOperating costs not itemised in the filing's summary | $262.0M | $180.0M | $180.0M | $176.0M |
| Total operating expenses | $2.72B | $2.72B | $2.87B | $2.84B |
| What was left | ||||
| Operating profitOperating income | $1.14B | $1.96B | $936.0M | $1.66B |
| Interest on debtInterest expense | $157.0M | $381.0M | $148.0M | $141.0M |
| Profit before tax | $1.03B | $1.71B | $850.0M | $1.56B |
| TaxIncome tax expense | $170.0M | $856.0M | $105.0M | $288.0M |
| Net profitNet income | $859.0M | $849.0M | $745.0M | $1.28B |
| EBITDAEarnings before interest, tax, depreciation, amortisation | $1.36B | $2.03B | $1.30B | $1.56B |
Business quality, value, and expectations at a glance.
Fundamentals
Reasonably priced and profitable.
Valuation
Quality
Growth
Filed positions and reported activity tied to this stock.
8 funds hold a position and insiders have been net selling.
Real smart money
Insiders
Politicians
Trend, range, and the price levels that matter.
Technicals
This stock is under pressure.
Trend
Under pressure
35 / 100
RSI 14
20D volatility
52-week range
$325.7020D support
20D resistance
Returns
Price vs moving averages
Volume pace
Recent coverage and its overall tone.
News
Coverage leans bullish
18 bullish · 28 neutral · 4 bearish
Tone of tracked coverage
SYK Stock Gains 3.8% Since March-End: What's Driving the Uptrend?
Leans bullishAug 14Stryker Corp. stock underperforms Thursday when compared to competitors
BearishAug 13Can Stryker's Q2 Recovery and Guidance Support a Stronger Second Half?
Leans bullishAug 13Stryker Up 13.6% in 3 Months as Recovery Gains Strength, What's Next?
Leans bullishAug 13Will Zimmer Biomet’s Upgraded 2026 Guidance and Buyback Shift Zimmer Biomet Holdings’ (ZBH) Narrative
Leans bullishAug 13Citigroup Adjusts Price Target on Stryker to $399 From $385, Maintains Buy Rating
Leans bullishAug 13Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle
NeutralAug 13Global X Robotics & Artificial Intelligence ETF (NASDAQ: BOTZ) Stock Price, News & Analysis
Leans bullishAug 13$15K
sold
AlphaYou
